Hemispherx Biopharma (HEB) Announces Compliance with NYSE Continued Listing Standards

September 19, 2016 8:37 AM EDT

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Hemispherx Biopharma (NYSE: HEB) announced today that, based on a notice received on September 15, 2016 from the New York Stock Exchange, Inc., the Company has regained compliance with the NYSE MKT’s continued listing standards set forth in Part 10 of the NYSE MKT Company Guide.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News

Add Your Comment